Press Releases

Unedited news and product information from vendors.

Cymer Reports Second Quarter 2010 Operating Results
Jul 22, 2010 (04:07 PM EDT)


SAN DIEGO, July 22 /PRNewswire-FirstCall/ -- Cymer, Inc. (Nasdaq: CYMI), the world's leading supplier of light sources used by chipmakers to create advanced semiconductor chips, today announced operating results for the second quarter ended June 30, 2010.

(Logo:  http://photos.prnewswire.com/prnh/20090406/LA94420LOGO)

(Logo:  http://www.newscom.com/cgi-bin/prnh/20090406/LA94420LOGO)

For the second quarter of 2010:

  • net income totaled $21,212,000 equal to $0.70 per share (diluted), compared to net income of $525,000, equal to $0.02 per share (diluted) in the second quarter of 2009 and net income of $16,005,000, equal to $0.53 per share (diluted), in the first quarter of 2010.  
  • revenue totaled $131,864,000 compared to revenue of $62,433,000 in the second quarter of 2009, and revenue of $113,781,000 in the first quarter of 2010.

Commenting on second quarter results, Bob Akins, Cymer's chief executive officer, said, "Second quarter revenue increased 16 percent over the first quarter of 2010.  The increase was attributable to higher light source sales, increased pulse utilization, a larger percentage of ArF pulses, and the first TCZ silicon crystallization tool sale.  Customer adoption of OnPulse continued to increase, and we now have over 50 percent of our active installed base under OnPulse coverage.  We are pleased with the selections of the XLR600ix for immersion lithography in all three chipmaking sectors and we shipped our first extreme ultraviolet (EUV) pilot source to ASML in April," said Akins.

"This month, we announced the introduction of the world's first field-selectable 30 to 50 watt KrF light source, the ELS 7010x.  We also shipped our second EUV pilot source to ASML, and a second TCZ silicon crystallization tool to another display maker in Asia," concluded Akins.  

In the second quarter of 2010, the company shipped 30 light sources, of which 20 were ArF immersion and 10 were KrF.  The company installed 30 light sources at chipmaker locations during the quarter.  The company reported gross profit of $69.5 million for the second quarter of 2010, yielding a 53 percent gross margin.  Total operating expenses, which include research and development and selling and administrative expenses, were $38.3 million.  In the second quarter, the company continued to increase its investment in EUV source development and commercialization.  Total operating income was $31.2 million or approximately 24 percent of revenue.  The second quarter effective tax rate was 32 percent.  As of June 30, 2010, cash and investments totaled $154.0 million.

Deep ultraviolet (DUV) bookings for the second quarter of 2010 totaled $139.6 million, resulting in a book-to-bill ratio of 1.09.  Seventy one percent of the light source bookings in the second quarter were ArF immersion and 24 percent were KrF.  The company ended the quarter with a DUV backlog of approximately $55.6 million, with ArF immersion light sources comprising approximately 90 percent of the value of sources in backlog.

Company Outlook  

Commenting on the outlook, Akins stated, "Chipmakers in all three sectors continue to increase their technology and capacity investment in ArF immersion lithography as well as KrF capacity additions as they expand factory capability and utilization.  We believe our Installed Base Products and DUV light sources are well positioned to capture an increased share of this investment.  Our EUV investment is focused on ongoing performance improvement and delivery of additional pilot sources to ASML, integrating these sources into their EUV scanners, and ensuring field readiness to support sources at chipmaker sites, as well as beginning the initial design of our next generation EUV source for higher volume manufacturing."  

Based on information available at this time, Cymer is providing the following guidance for the third quarter of 2010:

  • Revenue to be in the range of $132 to $138 million.  
  • Gross margin to be approximately 51 percent.
  • R&D expenses to be approximately $25 million.
  • SG&A expenses to be approximately $17 million.
  • The effective tax rate to be approximately 32 percent.

Cymer's management will hold a conference call at 2:00 pm (PDT) today, July 22, 2010, to discuss second quarter 2010 operating results and third quarter 2010 guidance.  This press release, the conference call and accompanying slides may be accessed on the investor relations page of the company's Web site at www.cymer.com.

Forward Looking Statements  

Statements in this press release that are not strictly historical in nature are forward-looking statements.  These statements include, but are not limited to statements regarding the continuing increased adoption of OnPulse, the continuing increased investment in EUV source commercialization and development, the industry's transition to EUV lithography and the statements under the caption "Company Outlook" above.  These statements are predictions based on current information and expectations and involve a number of risks and uncertainties.  In addition, statements regarding backlog and book-to-bill ratios should not be read as predictions or projections of future performance.  Actual events or results may differ materially from those projected in any of such statements due to various factors, including but not limited to: the demand for semiconductors in general, and, in particular, for leading-edge devices with smaller geometries; cyclicality in the market for semiconductor manufacturing equipment; the timing of customer orders, shipments and acceptances; delays or cancellations by customers of their orders; the performance and market acceptance of the company's new products or technologies; new and enhanced product offerings by competitors; the company's ability to meet its production and product development schedules; the rate at which semiconductor manufacturers adopt new technologies and purchase and take delivery of photolithography tools from the company's customers; the company's ability to secure adequate supplies of critical components for its advanced products; the company's ability to manage its expense levels and unanticipated expenses; the company's ability to achieve its forecasted gross margin which includes its ability to absorb manufacturing costs; the company's ability to align its cost structure with forecasted business levels; the company's ability to manage its foreign currency exposure; the performance and conditions in the United States and world financial markets; the policies and actions of the United States and other governments; and general economic conditions.  For a discussion of these and other factors which may cause our actual events or results to differ from those projected, please refer to the company's most recent annual report on Form 10-K and quarterly reports on Form 10-Q, as well as other subsequent filings with the Securities and Exchange Commission (SEC).  You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release.  All forward-looking statements are qualified in their entirety by this cautionary statement, and the company undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of this press release.

About Cymer

Cymer, Inc. (Nasdaq: CYMI) is the market leader in developing light sources, used by chipmakers worldwide to pattern advanced semiconductor chips. Cymer's light sources have been widely adopted by the world's top chipmakers and the company's installed base comprises approximately 3,300 systems. Continuing its legacy of leadership, Cymer is currently pioneering the industry's transition to EUV lithography, the next viable step on the technology roadmap for the creation of smaller, faster chips. The company is headquartered in San Diego, Calif., and supports its customers from numerous offices around the globe. Cymer maintains a Web site to which it regularly posts press releases, SEC filings, and additional information about Cymer.  Interested persons can also subscribe to automated e-mail alerts or RSS feeds. Please visit www.cymer.com.

Cymer and all other Cymer product or service names used herein are either registered trademarks or trademarks of Cymer, Inc. Any other marks mentioned herein are the property of their respective holders.

CYMER, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data)

(unaudited)










Three Months Ended


Six Months Ended


June 30,


June 30,


2010


2009


2010


2009

Revenues:








  Product sales

$131,864


$62,319


$245,645


$118,614

  Product sales - related party

-


114


-


318









    Total revenues

131,864


62,433


245,645


118,932









Cost of revenues

62,373


38,311


119,338


73,269









Gross profit

69,491


24,122


126,307


45,663









Operating expenses:








  Research and development

21,617


14,285


41,502


32,728

  Sales and marketing

6,332


3,947


11,466


7,910

  General and administrative

10,346


6,430


19,557


13,674

  Restructuring

-


-


-


8,407




0





    Total operating expenses

38,295


24,662


72,525


62,719









Operating income (loss)

31,196


(540)


53,782


(17,056)









Other income (expense):








  Foreign currency exchange gain (loss)

(160)


455


(56)


(1,478)

  Interest and other income

173


418


313


1,021

  Interest and other expense

(139)


(90)


(316)


(853)









    Total other income (expense) - net

(126)


783


(59)


(1,310)

















Income (loss) before income tax expense (benefit)

31,070


243


53,723


(18,366)









Income tax expense (benefit)

9,858


452


16,654


(6,061)









Net income (loss)

$21,212


($209)


$37,069


($12,305)









  Net loss attributable to noncontrolling interest in subsidiary

-


734


148


1,343









Net income (loss) attributable to Cymer, Inc.

$21,212


$525


$37,217


($10,962)









Earnings (loss) per share:








Basic earnings (loss) per share

$0.71


$0.02


$1.25


($0.37)

  Weighted average common shares outstanding-basic

29,716


29,680


29,856


29,664









Diluted earnings (loss) per share

$0.70


$0.02


$1.23


($0.37)

  Weighted average common shares outstanding-diluted

30,127


29,845


30,194


29,664



CYMER, INC.

CONSOLIDATED BALANCE SHEETS

(in thousands)

(unaudited)






June 30,


December 31,


2010


2009

ASSETS




Current assets:




  Cash and cash equivalents

$78,809


$118,381

  Restricted cash

4,984


1,200

  Short-term investments

75,231


62,895

  Accounts receivable - net

114,380


76,792

  Accounts receivable - related party

-


732

  Inventories

202,966


185,077

  Deferred and prepaid income taxes

48,035


45,689

  Prepaid expenses and other assets

14,301


12,121





    Total current assets

538,706


502,887





Property and equipment-net

102,066


106,755

Long-term investments

-


5,167

Deferred income taxes

29,652


26,998

Goodwill

8,833


8,833

Intangible assets-net

7,986


8,327

Other assets

5,200


5,951





Total assets

$692,443


$664,918





LIABILITIES




Current liabilities:




  Accounts payable

$31,908


$21,756

  Accounts payable - related party

127


9,284

  Accrued warranty

11,985


16,640

  Accrued payroll and benefits

22,726


16,434

  Deferred and accrued income taxes

5,191


12,363

  Deferred revenue

20,810


22,339

  Accrued and other current liabilities

11,527


4,807





    Total current liabilities

104,274


103,623

Accrued income taxes

14,612


11,562

Deferred revenue

681


525

Other liabilities

6,324


7,570





    Total liabilities

125,891


123,280





EQUITY




Cymer, Inc. stockholders' equity:




  Preferred stock

-


-

  Common stock

43


43

  Additional paid-in capital

607,788


598,314

  Treasury stock at cost

(492,890)


(473,580)

  Accumulated other comprehensive loss

(8,356)


(8,280)

  Retained earnings

459,967


422,750

    Total Cymer, Inc. stockholders' equity

566,552


539,247

  Noncontrolling interest

-


2,391

  Total equity

566,552


541,638





Total liabilities and equity

$692,443


$664,918



CYMER, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(unaudited)








Six months Ended


June 30,



2010

2009






Operating activities:





  Net income (loss)


$37,069


($12,305)

  Adjustments to reconcile net income (loss) to net cash (used in) provided by





    operating activities:





    Depreciation and amortization


9,789


11,672

    Stock-based compensation


5,180


2,169

    Bad debt expense


(696)


1,218

    Excess tax benefits from stock option exercises


(1,370)


(42)

    Provision for deferred income taxes


(3,669)


493

    Loss on disposal or impairment of property and equipment


61


584

    Change in assets and liabilities:





      Restricted cash


(3,754)


-

      Accounts receivable


(36,676)


16,637

      Accounts receivable - related party


732


546

      Inventories


(17,745)


18,358

      Prepaid expenses and other assets


(1,434)


1,108

      Income taxes receivable


-


(9,085)

      Accounts payable


12,520


(4,071)

      Accounts payable - related party


(9,157)


(763)

      Accrued expenses and other liabilities


5,998


(20,959)

      Deferred revenue


(1,362)


(1,173)

      Income taxes payable and accrued income taxes


(3,895)


(2,146)






         Net cash (used in) provided by operating activities


(8,409)


2,241






Investing activities:





  Acquisition of property and equipment


(7,879)


(4,063)

  Purchases of investments


(57,880)


(26,147)

  Proceeds from sold or matured investments


50,659


22,329






         Net cash used in investing activities


(15,100)


(7,881)






Financing activities:





  Proceeds from issuance of common stock


3,017


1,360

  Purchase of non-controlling interest


(1,456)


-

  Repayment of convertible subordinated note


-


(140,722)

  Excess tax benefits from stock option exercises


1,370


42

  Repurchase of common stock into treasury


(19,310)


-






         Net cash used in financing activities


(16,379)


(139,320)











Effect of exchange rate changes on cash and cash equivalents


316


(1,982)






Net decrease in cash and cash equivalents


(39,572)


(146,942)

Cash and cash equivalents at beginning of the period


118,381


252,391






Cash and cash equivalents at end of the period


$78,809


$105,449






Supplemental disclosure of cash flow information:





  Interest paid


$196


$2,654

  Income taxes paid


$24,143


$5,990






Supplemental disclosure of non cash operating, investing and financing activities:





Net (decrease) increase in acquisition of property and equipment included in accounts payable


($2,268)


$330

Net (decrease) increase in in-transit proceeds from issuance of common stock


($81)


$45



SOURCE Cymer, Inc.